BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12005540)

  • 1. Quantitative analysis of varying profiles of hypoxia in relation to functional vessels in different human glioma xenograft lines.
    Rijken PF; Peters JP; Van der Kogel AJ
    Radiat Res; 2002 Jun; 157(6):626-32. PubMed ID: 12005540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
    Rijken PF; Bernsen HJ; Peters JP; Hodgkiss RJ; Raleigh JA; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):571-82. PubMed ID: 10974478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.
    Bernsen HJ; Rijken PF; Peters JP; Bakker JH; Boerman RH; Wesseling P; van der Kogel AJ
    J Neurooncol; 1999 Sep; 44(2):129-36. PubMed ID: 10619496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia in a human intracerebral glioma model.
    Bernsen HJ; Rijken PF; Peters H; Raleigh JA; Jeuken JW; Wesseling P; van der Kogel AJ
    J Neurosurg; 2000 Sep; 93(3):449-54. PubMed ID: 10969943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the neovascular permeability in glioma xenografts by dynamic T(1) MRI with Gadomer-17.
    Verhoye M; van der Sanden BP; Rijken PF; Peters HP; Van der Kogel AJ; Pée G; Vanhoutte G; Heerschap A; Van der Linden A
    Magn Reson Med; 2002 Feb; 47(2):305-13. PubMed ID: 11810674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts.
    Scigliano S; Pinel S; Poussier S; Fouyssac F; Plenat F; Karcher G; Chastagner P
    Int J Oncol; 2008 Jan; 32(1):69-77. PubMed ID: 18097544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
    Yaromina A; Quennet V; Zips D; Meyer S; Shakirin G; Walenta S; Mueller-Klieser W; Baumann M
    Int J Radiat Biol; 2009 Nov; 85(11):972-80. PubMed ID: 19895274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites.
    Bernsen HJ; Rijken PF; Hagemeier NE; van der Kogel AJ
    Microvasc Res; 1999 May; 57(3):244-57. PubMed ID: 10329251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection.
    Zoula S; Rijken PF; Peters JP; Farion R; Van der Sanden BP; Van der Kogel AJ; Décorps M; Rémy C
    Br J Cancer; 2003 May; 88(9):1439-44. PubMed ID: 12778075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines.
    Bussink J; Kaanders JH; Strik AM; Vojnovic B; van Der Kogel AJ
    Radiat Res; 2000 Nov; 154(5):547-55. PubMed ID: 11025651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
    He F; Deng X; Wen B; Liu Y; Sun X; Xing L; Minami A; Huang Y; Chen Q; Zanzonico PB; Ling CC; Li GC
    Cancer Res; 2008 Oct; 68(20):8597-606. PubMed ID: 18922936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.
    Bernsen HJ; Rijken PF; Oostendorp T; van der Kogel AJ
    Br J Cancer; 1995 Apr; 71(4):721-6. PubMed ID: 7710935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.
    Ljungkvist AS; Bussink J; Rijken PF; Kaanders JH; van der Kogel AJ; Denekamp J
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):215-28. PubMed ID: 12182995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
    Wack LJ; Mönnich D; Yaromina A; Zips D; Baumann M; Thorwarth D
    Med Phys; 2016 Jul; 43(7):4113. PubMed ID: 27370131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
    Fokas E; Hänze J; Kamlah F; Eul BG; Lang N; Keil B; Heverhagen JT; Engenhart-Cabillic R; An H; Rose F
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1500-8. PubMed ID: 20637978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
    Olive PL; Aquino-Parsons C; MacPhail SH; Liao SY; Raleigh JA; Lerman MI; Stanbridge EJ
    Cancer Res; 2001 Dec; 61(24):8924-9. PubMed ID: 11751418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide.
    Bussink J; Kaanders JH; Rijken PF; Peters JP; Hodgkiss RJ; Marres HA; van der Kogel AJ
    Radiother Oncol; 1999 Feb; 50(2):173-84. PubMed ID: 10368041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.
    Busk M; Munk OL; Jakobsen S; Wang T; Skals M; Steiniche T; Horsman MR; Overgaard J
    Acta Oncol; 2010 Oct; 49(7):922-33. PubMed ID: 20831479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.